)
)
)
)
24 Jul 2023
LGC acquires Kova International, Inc., including Biochemical Diagnostics, Inc., strengthening its portfolio of Quality Measurement Tools
)
LGC Clinical Diagnostics, a business unit of LGC, announced the acquisition of Kova International, Inc. (Kova), a leading developer and manufacturer of in vitro urinalysis and toxicology quality control products for clinical laboratories
Kova includes two locations; Garden Grove, California, focused on urinalysis quality controls, and Edgewood, New York, focused on toxicology quality controls. Kova’s quality controls are used in hospitals, employee wellness programmes, forensic testing and medical device manufacturers production and Quality Assurance (QA) programs.
Bharathi Anekella, Executive Vice President & General Manager of LGC Clinical Diagnostics, said, “We are excited to bring Kova’s established clinical urinalysis and toxicology quality controls into LGC Clinical Diagnostics. Kova and LGC Clinical Diagnostics are an excellent fit. Our focus on delivering confidence to clinical laboratories in test precision, accuracy, and conformance to international standards, perfectly aligns us with a common objective of Science for a Safer World.”
Kova’s California and New York manufacturing facilities are certified to ISO 13485:2016 quality management system standards and guidelines, as well as cGMP qualified to manufacture quality control products, and are registered FDA manufacturing sites for the clinical diagnostic laboratory industry.
The acquisition grows LGC Clinical Diagnostics’ portfolio in the clinical quality control space, complementing a wide breadth of existing capabilities across biochemistry, serology, molecular, and clinical genomics quality controls and reference materials. LCC Clinical Diagnostics is also a leading provider of biological materials and viral antigens.
With over 35 years Industry experience, and now serving over 20,000 customers in more than 100 counties, we look forward to combining Kova’s and LGC Clinical Diagnostics’ expertise to deliver unrivalled solutions for our customers with an expanded breadth of capability.